Companies Dominating the Asia Pacific Alzheimer's Diagnosis and Treatment Landscape
- Sysmex Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Daiichi Sankyo Company Limited
- Sun Pharmaceutical Industries Ltd.
- Alkem Laboratories Ltd.
- Lupin Pharmaceuticals, Inc.
- TauRx Therapeutics Ltd.
- Merz Pharma GmbH & Co. KGaA
- AbbVie Inc.
- Siemens Healthcare Private Limited
- Eli Lilly and Company
- Biogen Inc.
- Eisai Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Increasing cases of Alzheimer's disease, a growing population of elderly, higher drug development, and proactive efforts by the government to help the patients are the major factors driving the market growth.
The market is anticipated to attain a CAGR of 14.6% over the forecast period, i.e., 2023-2033.
Lack of awareness regarding Alzheimer's disease, higher rate of drug failure, and long and expensive process of drug development is estimated to be the growth hindering factors for the market expansion.
The market in the China region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
The major players in the market are Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Lupin Pharmaceuticals, Inc., TauRx Therapeutics Ltd., Merz Pharma GmbH & Co. KGaA, AbbVie Inc., Siemens Healthcare Private Limited, Eli Lilly and Company, Biogen Inc., and Eisai Co., Ltd.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by treatment, treatment provider, diagnosis method, distribution channel, and by region.
The PET scan segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
